Ekaterini Syrigou
- Dermatology top 2%
- Immunology and Allergy top 2%
- Pharmacology top 5%
- Physiology top 10%
- Oncology
- Co-authors
- Muhammad Wasif SaifNektaria MakriliaLeonidas ManolopoulosIoannis KaklamanosKostas SyrigosPlaton S. PapageorgiouThierry BatardC. André
- Topics
- Drug-Induced Adverse Reactions (14 papers)Chemotherapy-related skin toxicity (7 papers)Urticaria and Related Conditions (6 papers)
- Journals
- Clinical Infectious DiseasesJournal of Allergy and Clinical ImmunologyEuropean Journal of Cancer
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Ekaterini Syrigou
35 papers receiving 795 citations
Peers
Comparison fields: 5 of 98
- Dermatology 265
- Immunology and Allergy 237
- Pharmacology 227
- Physiology 217
- Oncology 154
Countries citing papers authored by Ekaterini Syrigou
This map shows the geographic impact of Ekaterini Syrigou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekaterini Syrigou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekaterini Syrigou more than expected).
Fields of papers citing papers by Ekaterini Syrigou
This network shows the impact of papers produced by Ekaterini Syrigou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekaterini Syrigou. The network helps show where Ekaterini Syrigou may publish in the future.
Co-authorship network of co-authors of Ekaterini Syrigou
This figure shows the co-authorship network connecting the top 25 collaborators of Ekaterini Syrigou. A scholar is included among the top collaborators of Ekaterini Syrigou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekaterini Syrigou. Ekaterini Syrigou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 22 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 9 | |
| 7 | 37 | |
| 8 | 18 | |
| 9 | 24 | |
| 10 | 163 | |
| 11 | 31 | |
| 12 | 39 | |
| 13 | 39 | |
| 14 | 66 | |
| 15 | 12 | |
| 16 | 5 | |
| 17 | 157 | |
| 18 | 27 | |
| 19 | 6 | |
| 20 | 16 |
About Ekaterini Syrigou
Ekaterini Syrigou is a scholar working on Dermatology, Immunology and Allergy and Pharmacology, having authored 36 papers that have together received 829 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (14 papers), Chemotherapy-related skin toxicity (7 papers) and Urticaria and Related Conditions (6 papers). The work is most often cited by research in Immunology and Allergy (237 citations), Dermatology (265 citations) and Pharmacology (227 citations). Ekaterini Syrigou has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Muhammad Wasif Saif, Nektaria Makrilia, Leonidas Manolopoulos, Ioannis Kaklamanos, Kostas Syrigos, Platon S. Papageorgiou, Thierry Batard, C. André, F. Carat and Kevin J. Harrington. Their work appears in journals such as Clinical Infectious Diseases, Journal of Allergy and Clinical Immunology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.